Sputum biomarkers in COPD exacerbations

S. Soter, I. Barta, B. Antus (Budapest, Hungary)

Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Session: Monitoring exacerbations of airway diseases
Session type: Thematic Poster Session
Number: 914
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Soter, I. Barta, B. Antus (Budapest, Hungary). Sputum biomarkers in COPD exacerbations. Eur Respir J 2011; 38: Suppl. 55, 914

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sputum biomarkers in stable COPD
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011

Sputum colour as a marker of acute bacterial exacerbations of COPD
Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations
Year: 2003


Sputum neutrophilic markers in asthma of varying severity and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 550s
Year: 2003

Microbiological indicators from sputum of patients with exacerbation of COPD
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015


The BAL in the bacteriologic etiology in the COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005

Serum periostin in patients hospitalized for COPD exacerbations
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap
Source: Eur Respir J 2014; 43: 421-429
Year: 2013



Prediction of imminent COPD exacerbations by sputum analysis
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003

Sputum bacteriology in acute COPD exacerbations: correlation with FEV1 deterioration
Source: Eur Respir J 2001; 18: Suppl. 33, 189s
Year: 2001

Changes in the induced sputum proteome during COPD exacerbations
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020


An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004

Evaluation of markers for exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 283s
Year: 2005

Pulmonary biomarkers in asthma and COPD
Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Year: 2007

Blood biomarkers in asthma and COPD
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017


Applications of induced sputum sampling in asthma and COPD
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD
Source: Eur Respir J 2012; 40: 1344-1353
Year: 2012



Cytokines profile of blood and sputum in COPD exacerbation
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009

Cytokines profile of blood and sputum in COPD exacerbation
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

Sputum biomarkers of inflammation in smokers and subjects with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Cells biomarkers of bronchial brush-biopsies at COPD exacerbation
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013